Prescribing direct‐acting oral anticoagulants – Mind the evidence gap
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15450
Abstract: Direct‐acting oral anticoagulants (DOACs) are licensed for the prevention of thromboembolism in non‐valvular atrial fibrillation, amongst other indications. Prescribers use information derived from the summary of product characteristics which is based on the key trials… read more here.
Keywords: prescribing direct; acting oral; evidence; direct acting ... See more keywords